CIBC Private Wealth Group
SANA icon

CIBC Private Wealth Group’s Sana Biotechnology SANA Stock Holding History

CIBC Private Wealth Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$16 Hold
4
– – ﹤0.01% 3375
2025
Q3 		$14 Sell
4
-500
-99% -$1.81K ﹤0.01% 3058
2025
Q2 		$1.38K Buy
504
+4
+0.8% +$8 ﹤0.01% 2720
2025
Q1 		$670 Hold
500
– – ﹤0.01% 2861
2024
Q4 		$2.15K Sell
500
-125
-20% -$373 ﹤0.01% 2683
2024
Q3 		$2.6K Hold
625
– – ﹤0.01% 2757
2024
Q2 		$3.17K Hold
625
– – ﹤0.01% 2659
2024
Q1 		$6.33K Buy
+625
New +$4.68K ﹤0.01% 2439

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

CIBC Private Wealth Group's SANA Position: Q4 2025 in Review

CIBC Private Wealth Group held its Sana Biotechnology (SANA) position steady in Q4 2025 at 4 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #3375.

CIBC Private Wealth Group first reported a position in SANA in Q1 2024 and has held it in 8 quarters since. The position peaked at $6.33K in Q1 2024. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • CIBC Private Wealth Group held 4 shares of Sana Biotechnology worth $16 as of Q4 2025.
  • CIBC Private Wealth Group left its Sana Biotechnology share count unchanged in Q4 2025.
  • Sana Biotechnology made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3375 holding.
  • CIBC Private Wealth Group first reported a position in Sana Biotechnology in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Sana Biotechnology position peaked at $6.33K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.